Medical ethicist Arthur Caplan voices concerns about human subject protection in clinical trials due to significant staff cuts at FDA and HHS.
A Wiley Rein petition filed for a client asks FDA to order the immediate withdrawal of Wells Pharma’s compounded 100 mg indomethacin suppository.
Medical ethicist Arthur Caplan voices concerns about human subject protection in clinical trials due to significant staff cuts at FDA and HHS.
A Wiley Rein petition filed for a client asks FDA to order the immediate withdrawal of Wells Pharma’s compounded 100 mg indomethacin suppository.
FDA approves Shanghai Henlius Biologics’ Poherdy (pertuzumab-dpzb), the first interchangeable biosimilar to Genentech’s Perjeta (pertuzumab), a HER2-targeted therapy for breast cancer.
University of Chicago researchers explain how difficult it will be to improve government oversight over social media influencer promotions for FDA-regulated products.
